DE69011557D1 - Verwendung von Purpuromycin zur Behandlung von Vaginalinfektionen. - Google Patents

Verwendung von Purpuromycin zur Behandlung von Vaginalinfektionen.

Info

Publication number
DE69011557D1
DE69011557D1 DE69011557T DE69011557T DE69011557D1 DE 69011557 D1 DE69011557 D1 DE 69011557D1 DE 69011557 T DE69011557 T DE 69011557T DE 69011557 T DE69011557 T DE 69011557T DE 69011557 D1 DE69011557 D1 DE 69011557D1
Authority
DE
Germany
Prior art keywords
purpuromycin
treatment
vaginalis
vaginal infections
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69011557T
Other languages
English (en)
Other versions
DE69011557T2 (de
Inventor
Francesco Parenti
Beth P Goldstein
Luigi Simioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of DE69011557D1 publication Critical patent/DE69011557D1/de
Publication of DE69011557T2 publication Critical patent/DE69011557T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69011557T 1989-03-31 1990-03-20 Verwendung von Purpuromycin zur Behandlung von Vaginalinfektionen. Expired - Fee Related DE69011557T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89105686 1989-03-31
EP89109272 1989-05-23

Publications (2)

Publication Number Publication Date
DE69011557D1 true DE69011557D1 (de) 1994-09-22
DE69011557T2 DE69011557T2 (de) 1995-03-23

Family

ID=26120030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69011557T Expired - Fee Related DE69011557T2 (de) 1989-03-31 1990-03-20 Verwendung von Purpuromycin zur Behandlung von Vaginalinfektionen.

Country Status (10)

Country Link
US (1) US5141953A (de)
EP (1) EP0389924B1 (de)
JP (1) JPH02289514A (de)
KR (1) KR900013971A (de)
AT (1) ATE109978T1 (de)
AU (1) AU628946B2 (de)
CA (1) CA2013277A1 (de)
DE (1) DE69011557T2 (de)
HU (1) HU207655B (de)
IL (1) IL93866A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447813A1 (de) * 1990-02-28 1991-09-25 GRUPPO LEPETIT S.p.A. Wasserlösliche Salze von Purpuromycin und dieses enthaltende pharmazeutische Zusammensetzungen
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
RU2316119C2 (ru) * 2002-01-04 2008-01-27 Нокиа Корпорейшн Высокоскоростная передача в режиме передачи и приема с разнесением
WO2005047475A2 (en) * 2003-11-11 2005-05-26 Regents Of The University Of Minnesota Regulation of cell membrane-mediated effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
PT3481370T (pt) 2016-07-08 2021-05-28 Acraf Composição farmacêutica compreendendo benzidamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1455128A (en) * 1973-03-19 1976-11-10 Lepetit Spa Purpuromycin and its derivatives

Also Published As

Publication number Publication date
AU5206390A (en) 1990-10-04
DE69011557T2 (de) 1995-03-23
HU207655B (en) 1993-05-28
EP0389924B1 (de) 1994-08-17
ATE109978T1 (de) 1994-09-15
HUT54299A (en) 1991-02-28
AU628946B2 (en) 1992-09-24
IL93866A0 (en) 1990-12-23
US5141953A (en) 1992-08-25
CA2013277A1 (en) 1990-09-30
KR900013971A (ko) 1990-10-22
JPH02289514A (ja) 1990-11-29
EP0389924A2 (de) 1990-10-03
HU901897D0 (en) 1990-07-28
EP0389924A3 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
ES2056963T3 (es) Agentes antibacterianos.
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
BR9306040A (pt) Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
ES2187667T3 (es) Uso de relaxina para estimular angiogenesis.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
IT9019141A1 (it) Trattamento di malattie associate ad infezioni di hiv
ATE81776T1 (de) Verwendung von chinolon und naphthyridinantibiotika zur herstellung von ophthalmischen arzneimitteln.
DK312688D0 (da) Glykkopeptid-antibiotika
OA09917A (en) Compounds for use in treating HIV infection
DE69011557D1 (de) Verwendung von Purpuromycin zur Behandlung von Vaginalinfektionen.
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
FR2694694B1 (fr) Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
SE8902124D0 (sv) Medel foer behandling aav herpesinfektioner
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
PT89582B (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
ATE70975T1 (de) Tiermedizinische zusammensetzung.
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
EE03063B1 (et) Farmatseutiline salv, mis on vaba nahka ärritavast toimest ja selle valmistamise protsess
ATE77743T1 (de) Behandlung von pilzinfektionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee